Jeffrey Zekaukas
Stock Analyst at JP Morgan
(1.12)
# 3,816
Out of 5,132 analysts
29
Total ratings
31.25%
Success rate
-1.71%
Average return
Main Sectors:
Stocks Rated by Jeffrey Zekaukas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EMN Eastman Chemical Company | Maintains: Overweight | $60 → $70 | $80.08 | -12.59% | 9 | Feb 2, 2026 | |
| MOS The Mosaic Company | Maintains: Neutral | $26 → $24 | $29.65 | -19.06% | 8 | Dec 5, 2025 | |
| ECL Ecolab | Downgrades: Neutral | $200 → $220 | $299.17 | -26.46% | 5 | Feb 14, 2024 | |
| LYB LyondellBasell Industries | Upgrades: Overweight | $95 → $100 | $57.61 | +73.58% | 3 | Feb 5, 2024 | |
| AVY Avery Dennison | Maintains: Overweight | $185 → $218 | $195.80 | +11.34% | 2 | Feb 1, 2024 | |
| LLY Eli Lilly and Company | Maintains: Equal-Weight | $148 → $157 | $1,040.00 | -84.90% | 2 | Aug 14, 2020 |
Eastman Chemical Company
Feb 2, 2026
Maintains: Overweight
Price Target: $60 → $70
Current: $80.08
Upside: -12.59%
The Mosaic Company
Dec 5, 2025
Maintains: Neutral
Price Target: $26 → $24
Current: $29.65
Upside: -19.06%
Ecolab
Feb 14, 2024
Downgrades: Neutral
Price Target: $200 → $220
Current: $299.17
Upside: -26.46%
LyondellBasell Industries
Feb 5, 2024
Upgrades: Overweight
Price Target: $95 → $100
Current: $57.61
Upside: +73.58%
Avery Dennison
Feb 1, 2024
Maintains: Overweight
Price Target: $185 → $218
Current: $195.80
Upside: +11.34%
Eli Lilly and Company
Aug 14, 2020
Maintains: Equal-Weight
Price Target: $148 → $157
Current: $1,040.00
Upside: -84.90%